HCID 44222369, compound → HCID 71252800, compound
Reaction equation
C([O:8][CH2:9][C@H:10]1[CH2:14][CH2:13][S:12](=[O:16])(=[O:15])[NH:11]1)C1C=CC=CC=1.[CH3:17][C:18]1[CH:23]=[C:22]([CH3:24])[CH:21]=[CH:20][C:19]=1[N:25]1[CH2:30][CH2:29][N:28]([C:31]([C:33]2[CH:38]=[CH:37][C:36](I)=[CH:35][CH:34]=2)=[O:32])[CH2:27][CH2:26]1>>[CH3:17][C:18]1[CH:23]=[C:22]([CH3:24])[CH:21]=[CH:20][C:19]=1[N:25]1[CH2:26][CH2:27][N:28]([C:31]([C:33]2[CH:38]=[CH:37][C:36]([N:11]3[C@@H:10]([CH2:9][OH:8])[CH2:14][CH2:13][S:12]3(=[O:15])=[O:16])=[CH:35][CH:34]=2)=[O:32])[CH2:29][CH2:30]1Participants
3
Procedure
Using (R)-3-benzyloxymethylisothiazolidine 1,1-dioxide (370 mg) described in Preparation Example 10 and [4-(2,4-dimethylphenyl)piperazin-1-yl](4-iodophenyl)methanone (643 mg) described in Preparation Example 108 and by the reaction and treatment in the same manner as in Example 32, the title compound (522 mg) was obtained.
Workup
- customdescribed in Preparation Example 108 and by the reaction and treatment in the same manner as in Example 32
Sources & evidence
- ORD record
- ord-5f0b122a71434b7891f29d60981477e3
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…